share_log

康希诺(688185.SH):部分控股股东合计使用约567.05万港币增持27.8万股H股

CanSino Biologics Inc. (688185.SH): Some controlling shareholders collectively used approximately 5.6705 million Hong Kong dollars to increase their Shareholding by 0.278 million shares Listed in Hong Kong.

Gelonghui Finance ·  Dec 20 17:35

Gelonghui, December 20 | Cansino (688185.SH) announced that it received a “Notice Letter” from some controlling shareholders XUEFENGYU (Yu Xuefeng), Zhu Tao, SHOUBAICHAO (Chao Shoubai) and Wang Jing, executive director and senior manager, on the completion of the plan to increase the company's H shares. During the implementation of this plan, XUEFENGYU (Yu Xuefeng), Zhu Tao, and SHOUBAICHAO (Chao Shoubai) increased their holdings based on their judgment on the securities market, capital increase arrangements, and increase window periods, etc. 100,000 shares, 110,000 shares and 68,000 H shares used a total of about HK$5.6705 million to increase the holding of 278,000 H shares, accounting for about 0.1123% of the company's total share capital. Meanwhile, XUEFENGYU (Yu Xuefeng), Zhu Tao, and SHOUBAICHAO (Chao Shoubai) did not reduce their holdings of the company during the implementation of this plan to increase their holdings.

Wang Jing is an executive director and senior manager of the company. Over the six months from June 21, 2024, she increased her holdings of the company's total H shares by a total of about HK$0.3497 million, accounting for about 0.0076% of the company's total share capital. As of the disclosure date of this announcement, it held 18,800 H shares of the company.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment